Skip to main content
. 2013 Aug 2;4:208. doi: 10.3389/fimmu.2013.00208

Table 1.

Subclasses of CD4+ T cells with regulatory function.

(A) PRESENT TO CONTROL AUTOIMMUNITY IN NORMAL HOSTS
nTreg produced in thymus and released into periphery, prevent activation of destructive autoimmune responses. Absence of nTreg due to neonatal thymectomy (19), lack of IL-2, CD25, or FoxP3 (223) leads to widespread autoimmunity. Expression of CTLA4 is required for function of nTreg (224). These cells will control low level immune responses, and suppress at a ratio of 1:1 with more aggressive immune responses (58) including fully allogeneic responses (57, 59). They inhibit antigen presenting cells by direct contact and act in peripheral lymphoid tissues not at sites of inflammation
Induced Treg generated when antigen is presented in a non-inflammatory environment, when TGF-β is present in the absence of activated antigen presenting cells and inflammatory cytokines such as IL-1β and IL-6. This produces additional Treg, that are antigen specific to prevent induction of autoimmune response, in situations where self antigen is released due to non-inflammatory tissue injury such as trauma, ischemia, or chemical injury of tissue as well as in normal tissue re-modeling and failed or incomplete apoptosis, reviewed (225). In these circumstances TGF-β produced to promote repair of tissue also induces iTreg to prevent unwanted and unnecessary autoimmune responses. Their survival is ephemeral if there is repair of tissue, but they may be further activated if inflammation supervenes
Th3 and Tr1 cells produced in mucosal sites, in response to antigens that penetrate the mucosa. There is abundant IL-10 and IL-10 family of cytokines, as well as TGF-β at these sites, that promotes tolerance induction to normal mucosal flora and oral antigens to prevent local and unwanted immune responses and inflammation that would disrupt the mucosal integrity. They are essential to the preservation of mucosal integrity and act by production of TGF-β and IL-10 that in turn promotes induction of more Th1 and Tr1
(B) PRESENT AFTER ACTIVATION OF AN IMMUNE RESPONSE TO A SPECIFIC ANTIGEN
Antigen Activation of nTreg by inflammatory immune responses with cytokines produced early after activation of effector CD4+ T cells. The best described is the effects of high concentrations of IL-2, inducing expansion of nTreg in the presence of a specific antigen. IL-4 also can induce activation of antigen specific Treg from nTreg. Th1 and Th2 responses induce expansion of antigen specific Treg, respectively called Ts1 and Ts2 cells, that control responses other that that of the inducing response. This contributes to polarization to one response, for example Th2 cytokine activated nTreg inhibit Th1 and Th17 responses
Activation of antigen specific activated nTreg by cytokines produced late in an ongoing immune response. This induces the Treg to express cytokines and transcription factors of the activated Th cells, so the Treg become Th-like and express the transcription factor and late cytokines of that Th lineage
Conversion of activated effector cells to regulatory cells
(i) Activated Treg infecting activated T cells, via IL-35/IL-10 (226) or surface TGF-β (227 ) to a regulatory T cell phenotype and function
(ii) Persistent activation of effector lineage induces them to produce IL-10 and dampen their own response as was described some 20 years ago (228230)